Kuiper, J. (author), van Teijlingen, M. (author), Vietsch, H. (author), Rijken, D.C. (author), van Berkel, T.J.C. (author), Blessen, E.A.L. (author), Division of Biopharmaceutics, LACDR, Leiden, Netherlands Gaubius Laboratory TNO Preventie en Gezondheid (author) A major complication of the use of of tissue-type plasminogen activator (t-PA) as fibrinolytic agent is its rapid clearance from the bloodstream. We have studied whether t-PA clearance can be reduced by preventing receptor-mediated endocytosis of t-PA in vivo via the mannose receptor and the low-density lipoprotein receptor related protein (LRP)...
article 1996